ATE415954T1 - Medizinische wirkstoffpflaster mit verringerter optischer auffälligkeit auf der haut - Google Patents

Medizinische wirkstoffpflaster mit verringerter optischer auffälligkeit auf der haut

Info

Publication number
ATE415954T1
ATE415954T1 AT04726478T AT04726478T ATE415954T1 AT E415954 T1 ATE415954 T1 AT E415954T1 AT 04726478 T AT04726478 T AT 04726478T AT 04726478 T AT04726478 T AT 04726478T AT E415954 T1 ATE415954 T1 AT E415954T1
Authority
AT
Austria
Prior art keywords
skin
patch
considerability
medical active
person
Prior art date
Application number
AT04726478T
Other languages
German (de)
English (en)
Inventor
Stefan Bracht
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33154271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE415954(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of ATE415954T1 publication Critical patent/ATE415954T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Spectrometry And Color Measurement (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Materials For Medical Uses (AREA)
AT04726478T 2003-04-17 2004-04-08 Medizinische wirkstoffpflaster mit verringerter optischer auffälligkeit auf der haut ATE415954T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10317692A DE10317692A1 (de) 2003-04-17 2003-04-17 Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut

Publications (1)

Publication Number Publication Date
ATE415954T1 true ATE415954T1 (de) 2008-12-15

Family

ID=33154271

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04726478T ATE415954T1 (de) 2003-04-17 2004-04-08 Medizinische wirkstoffpflaster mit verringerter optischer auffälligkeit auf der haut

Country Status (22)

Country Link
US (3) US10653636B2 (enExample)
EP (1) EP1615628B1 (enExample)
JP (2) JP5733875B2 (enExample)
KR (1) KR101052127B1 (enExample)
CN (1) CN100450472C (enExample)
AT (1) ATE415954T1 (enExample)
AU (1) AU2004229159B2 (enExample)
BR (1) BRPI0409889B8 (enExample)
CA (1) CA2522962C (enExample)
CY (1) CY1108832T1 (enExample)
DE (2) DE10317692A1 (enExample)
DK (1) DK1615628T3 (enExample)
ES (1) ES2320550T3 (enExample)
IL (1) IL171399A (enExample)
MX (1) MXPA05010935A (enExample)
NZ (1) NZ543195A (enExample)
PL (1) PL1615628T3 (enExample)
PT (1) PT1615628E (enExample)
RU (1) RU2336866C2 (enExample)
SI (1) SI1615628T1 (enExample)
WO (1) WO2004091590A1 (enExample)
ZA (1) ZA200507034B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
DE102005010255A1 (de) * 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
RU2367577C1 (ru) 2005-08-12 2009-09-20 Рик Б. ЙЕГЕР Система и способ для нанесения изменяющего отражательную способность вещества в целях улучшения визуальной привлекательности человеческой кожи
US8942775B2 (en) 2006-08-14 2015-01-27 Tcms Transparent Beauty Llc Handheld apparatus and method for the automated application of cosmetics and other substances
US8184901B2 (en) 2007-02-12 2012-05-22 Tcms Transparent Beauty Llc System and method for applying a reflectance modifying agent to change a person's appearance based on a digital image
JP5237112B2 (ja) * 2006-12-01 2013-07-17 日東電工株式会社 経皮吸収製剤
KR101408454B1 (ko) * 2006-12-01 2014-06-17 닛토덴코 가부시키가이샤 도네페질 함유 접착 제제의 착색을 억제하는 방법 및 도네페질의 친척 물질의 생성량을 감소시키는 방법
JP2010519185A (ja) 2007-02-12 2010-06-03 リック ビー． イェーガー， 作用物質を静電気的に人の皮膚に塗布するためのシステムおよび方法
US10092082B2 (en) 2007-05-29 2018-10-09 Tcms Transparent Beauty Llc Apparatus and method for the precision application of cosmetics
RU2483729C2 (ru) * 2008-05-30 2013-06-10 Нитто Денко Корпорейшн Чрескожно абсорбируемый препарат
RU2481826C2 (ru) * 2008-05-30 2013-05-20 Нитто Денко Корпорейшн Содержащий донепезил адгезивный препарат и упаковка для него
EP3310327A2 (en) * 2015-06-22 2018-04-25 Johnson & Johnson Consumer Inc. Method for providing a benefit to skin
JP7398750B2 (ja) * 2019-02-28 2023-12-15 パナソニックＩｐマネジメント株式会社 画像処理装置、画像処理方法およびシート

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE7529365U (de) 1976-01-08 Beiersdorf Ag, 2000 Hamburg Wund schnell verband
JPS55111416A (en) * 1979-02-20 1980-08-28 Taisho Pharmaceut Co Ltd Paster
US4594276A (en) * 1984-04-09 1986-06-10 Minnesota Mining And Manufacturing Company Printed, removable body tattoos on a translucent substrate
JPH0739566B2 (ja) 1986-02-21 1995-05-01 積水化学工業株式会社 医療用粘着テープもしくはシートの製造方法
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5004510A (en) * 1989-01-30 1991-04-02 Panzhihua Iron & Steel Co. Process for manufacturing high strength railroad rails
DE4030465C2 (de) * 1990-09-26 1994-06-01 Ruschke Mona Pflaster
US5120325A (en) * 1991-06-12 1992-06-09 Fleshtones Products Co., Inc. Color-matched sterile adhesive bandages containing melanin-like pigment composition
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US5264219A (en) * 1992-08-07 1993-11-23 Minnesota Mining And Manufacturing Company Transdermal drug delivery backing
JPH07206624A (ja) 1994-01-20 1995-08-08 Shiseido Co Ltd 皮膚外用剤
US5536263A (en) * 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
DE19519593C1 (de) * 1995-05-29 1996-08-29 Horstmann Michael Transdermales Therapeutisches System mit druckfarbenfreier Identifikation und Verfahren zu seiner Herstellung
TR199802659T2 (xx) * 1996-06-20 1999-03-22 Lavipharm S.A. Topikal akne tedavisi i�in bir ara� ve tedavi y�ntemi.
US6025535A (en) * 1996-10-28 2000-02-15 The Procter & Gamble Company Topsheet for absorbent articles exhibiting improved masking properties
JPH11116470A (ja) * 1997-08-12 1999-04-27 Takeda Chem Ind Ltd イデベノン含有経皮投与製剤
HUP0104728A3 (en) * 1998-12-18 2006-07-28 Alza Corp Mountain View Transparent transdermal nicotine delivery device
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
AU2000242314B2 (en) * 2000-04-12 2005-11-03 The Procter & Gamble Company Pre-formed sheet devices suitable for topical application
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
US8586079B2 (en) * 2002-06-21 2013-11-19 Graphic Productions Inc. Promotional simulation for transdermal patch sampler
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut

Also Published As

Publication number Publication date
JP2012092133A (ja) 2012-05-17
JP5733875B2 (ja) 2015-06-10
AU2004229159B2 (en) 2010-01-28
JP2006523637A (ja) 2006-10-19
EP1615628B1 (de) 2008-12-03
US20190160017A1 (en) 2019-05-30
BRPI0409889A (pt) 2006-05-23
AU2004229159A1 (en) 2004-10-28
BRPI0409889B1 (pt) 2019-12-17
US10646453B2 (en) 2020-05-12
EP1615628A1 (de) 2006-01-18
DK1615628T3 (da) 2009-04-06
IL171399A (en) 2015-02-26
CA2522962A1 (en) 2004-10-28
MXPA05010935A (es) 2005-11-25
US20200206147A1 (en) 2020-07-02
HK1079455A1 (zh) 2006-04-07
CN100450472C (zh) 2009-01-14
KR101052127B1 (ko) 2011-07-26
ZA200507034B (en) 2006-05-31
PT1615628E (pt) 2009-03-11
PL1615628T3 (pl) 2009-06-30
KR20050114724A (ko) 2005-12-06
RU2336866C2 (ru) 2008-10-27
CA2522962C (en) 2011-11-01
DE10317692A1 (de) 2004-11-11
US20070116751A1 (en) 2007-05-24
US10653636B2 (en) 2020-05-19
NZ543195A (en) 2009-04-30
US11426358B2 (en) 2022-08-30
ES2320550T3 (es) 2009-05-25
RU2005129528A (ru) 2006-05-10
DE502004008582D1 (de) 2009-01-15
WO2004091590A1 (de) 2004-10-28
BRPI0409889B8 (pt) 2021-05-25
CY1108832T1 (el) 2014-07-02
SI1615628T1 (sl) 2009-04-30
CN1826103A (zh) 2006-08-30

Similar Documents

Publication Publication Date Title
CY1108832T1 (el) Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα
ES2091918T3 (es) Estratificados elasticos modificados en el espacio.
BR0102637A (pt) Curativo adesivo
MX9307522A (es) Laminado abultado estirado-acojinado.
DE602004018154D1 (de) Mehrschichtige medizinprodukte
ES2052210T3 (es) Pelicula compuesta para el tratamiento de superficies y procedimientos de fabricacion correspondientes.
CL2004000674A1 (es) Sistema terapeutico transdermico que comprende al menos una sustancia activa farmaceutica, al menos un disruptor de la estructura y/o al menos un formador de estructura en una matriz comun.
MX9206493A (es) TELA DE CAPAS MULTIPLES ADMINISTRADORA DE HUMEDAD Y PRENDAS DE VESTIR QUE INCORPORAN UN PAñO ADMINISTRADOR DE HUMEDAD
PE119199A1 (es) Terapia en combinacion para erradicar vhc-arn detectable en pacientes que padecen infeccion por hepatitis c cronica
ATE353655T1 (de) Myo-inositol hexaphosphat zur topischen verwendung
US20120316519A1 (en) Tape Preparation
AR033748A1 (es) Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
ATE281848T1 (de) Transdermales therapeutisches system zur abgabe von wirkstoffen über die haut an den menschlichen körper
YU14394A (sh) Flaster sa aktivnom supstancom za davanje estradiola na kožu
HUP0302660A2 (hu) Rétegelt anyag testrészek védelmére és a rétegelt anyagot tartalmazó eszköz
ES2194261T3 (es) Preparaciones de absorcion percutanea estabilizadas.
ATE445393T1 (de) Tablette mit gefärbtem kern
CO5520034A1 (es) Toalla femenina o panti-protector de colores
CO5640059A2 (es) Uso de clorofila para el control de malos olores en articulos absorbentes desechables
DE502005008493D1 (de) Kompresse für die kombinierte applikation von naturheilstoffen und elektromagnetischen strahlungen
DE59504233D1 (de) Estradiol-tts mit wasserbindenden zusätzen
ES2504365T3 (es) La actividad neuroprotectora de la proteína C activada es independiente de su actividad anticoagulante
Eggertson Canadian doctor led bombing response at a Boston hospital
Josefson Calcium channel blockers inferior to cheaper drugs
Farmer skin disease is attributable to infectious agents. However, poor nutrition